HomeDrug Discovery

Drug Discovery

LabGenius Unveils Breakthrough Bispecific T-Cell Engager With Strong Tumor Response Ahead of ESMO IO 2025

AI-powered discovery platform EVA™ drives development of a highly selective T-cell engager showing over 90% tumor growth inhibition in pre-clinical studies. London, 13 November 2025...

Carving a Resolution for One Hidden Detriment of Mental Health Diseases

Neurocrine Biosciences, Inc. has officially published top-line data from a Phase 4 study named KINECT-PRO™ data, which showcases clinically meaningful and sustained effects of...

Reinforcing the Efficacy of a Much-awaited Answer to the Migraine Problem

Axsome Therapeutics, Inc., a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, has officially published results from...

Innovative Technologies Accelerating First-In-Human to Proof-of-Concept

During the earliest stages of clinical drug development, pharmaceutical and biotech companies need to make critical go / no-go decisions for their investigational products....

Developing Animal Free Organoid Models for Drug Discovery

There is an increasing drive within the pharmaceutical and personal care communities to reduce, if not eliminate, the use of animals in the testing...

Hot Topics